Concepedia

Publication | Open Access

Combination of Dll4/Notch and Ephrin-B2/EphB4 targeted therapy is highly effective in disrupting tumor angiogenesis

92

Citations

34

References

2010

Year

Abstract

Combination targeting of Dll4/Notch and Ephrin-B2/EphB4 has potential for clinical investigation, providing cumulative efficacy and increased safety over Dll4/Notch inhibition alone.

References

YearCitations

1995

1.8K

1985

1.3K

2010

1.3K

2003

1.2K

2003

1.2K

1999

1K

2006

1K

1999

987

2006

978

2007

781

Page 1